Lenvatinib, sintilimab combined interventional treatment vs bevacizumab, sintilimab combined interventional treatment for intermediate-advanced unresectable hepatocellular carcinoma., PMID:39575400
Neisseria gonorrhoeae induces local secretion of IL-10 at the human cervix to promote colonization., PMID:39585777
A bio-nano-engineered platform fabricated from cerium oxide-carbon nanoparticles stabilized with chitosan for label-free sensing of a lung cancer biomarker., PMID:39633582
Enrichment of carcinoembryonic antigen by epitope molecularly imprinted polymer based on cucurbituril host-guest interaction., PMID:39644742
Antibody-modified 2D MXene nanosheet probes for selective, picolevel detection of cancer biomarkers., PMID:39647410
Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 Tumors., PMID:39682238
Expression-Dependent Tumor Pretargeting via Engineered Avidity., PMID:39704255
Point-of-Care Detection of Carcinoembryonic Antigen (CEA) Using a Smartphone-Based, Label-Free Electrochemical Immunosensor with Multilayer CuONPs/CNTs/GO on a Disposable Screen-Printed Electrode., PMID:39727865
Impedimetric Biosensors for the Quantification of Serum Biomarkers for Early Detection of Lung Cancer., PMID:39727890
Characteristics of Nodular Goitre and Its Correlation With Papillary Thyroid Carcinoma: A Cross-Sectional Study., PMID:39737304
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients-The Putative Mechanism Behind ILD., PMID:39754485
Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy., PMID:39759518
Electrochemical biosensor based on composite of gold nanoparticle/reduced-graphene oxide/graphitic carbon nitride and a caprolactone polymer for highly sensitive detection of CEA., PMID:39764934
Affinity Peptide-Based Circularly Permuted Fluorescent Protein Biosensors for Non-Small Cell Lung Cancer Diagnosis., PMID:39771637
Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: State of the Art and Future Perspectives., PMID:39796075
Broad-Spectrum Efficacy of CEACAM6-Targeted Antibody-Drug Conjugate with BET Protein Degrader in Colorectal, Lung, and Breast Cancer Mouse Models., PMID:39812376
Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring., PMID:39841472
Bright and Specific Targeting of Metastatic Lymph Nodes in Orthotopic Mouse Models of Gastric Cancer with a Fluorescent Anti-CEA Antibody., PMID:39878844
Alkaline Phosphatase: A Prognostic Biomarker in Non-Metastatic Colon Adenocarcinoma Patients - A Single-Centre Study., PMID:39936196
Bi2WO6-labeled antibody induced photocurrent polarity switching of ZnIn2S4-based photoelectrochemical immunosensor for the highly sensitive detection of carcinoembryonic antigen., PMID:39951987
Multifunctional dopamine-modified conjugated polymer nanoparticles for ultrasensitive immunoassays., PMID:39955906
Bidirectionally Favorable Platform: A Dual-Targeting Probe-Encoded Maple Leaf-Type Fluorescent Lateral Flow Immunoassay for Multiple Biomarker Detection., PMID:39962727
A Dual Nano-Signal Probe-Based Electrochemical Immunosensor for the Simultaneous Detection of Two Biomarkers in Gastric Cancer., PMID:39996982
Ultrasensitive CEA detection using SiO2/AuNPs-mediated dual inhibition in a signal-off-type photoelectrochemical immunosensor., PMID:40015784
Integrated Device for Cancer Nucleic Acid Biomarker Detection at Body Temperature., PMID:40047709
Highly sensitive detection of carcinoembryonic antigen via an electrochemical platform fabricated by CCLP- gold nanocomposite., PMID:40049234
Gold Nanoparticle Incorporated Graphene Oxide as a SERS Platform for Ultratrace Antibody Free Sensing of the Cancer Biomarker CEA., PMID:40062598
Harnessing bifunctional nanozyme with potent catalytic and signal amplification for innovating electrochemical immunoassay., PMID:40064571
Development of Anti-CEA CH2 Domain-Deleted Antibody (M5A∆CH2) for the PET Imaging of Colorectal Cancer., PMID:40085171
Cerebrospinal fluid cytology for the diagnosis of lung cancer brain metastasis: a case report., PMID:40114958
New World Primates and Their Human Counterparts Share Diseases That Abound with CEACAM and Other Effector Molecules., PMID:40141825
A high-affinity antibody-drug conjugates Actuximab-MMAE for potent and selective targeting of CEACAM5-Positive tumors., PMID:40158720
FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters: A post hoc analysis of the randomized open-label phase III trial FIRE-3/AIO KRK0306., PMID:40179821
Multimodal carcinoembryonic antigen-targeted fluorescence and radio-guided cytoreductive surgery for peritoneal metastases of colorectal origin: single-arm confirmatory trial., PMID:40270484
Dual-channel, real-time, long-term stable electrochemical immunosensor based on Au, Cu-vertical graphene for detection of carcinoembryonic antigen in tumor cells., PMID:40274336
Plasma IgG and IgM autoantibodies to COPT1 as potential biomarkers for detection of non-small cell lung cancer., PMID:40292291
Self-assembled nano-hybrid composite based on Cu/CuXO nanoflower decorated onto hBNNS for high-performance and ultra-sensitive electrochemical detection of CEA biomarker., PMID:40315690
Bifunctional S-doping-mediated interfacial gradient electric field for in-situ amplified photoelectrochemical immunoassay., PMID:40319725
Artificial intelligence prediction of carcinoembryonic antigen structure and interactions relevant for colorectal cancer., PMID:40330074
Modulation of Aggregation of Covalent Organic Framework Nanosheets with Aggregation-Induced Emission Activity for Ultrasensitive No-Wash Fluorescent Immunosensor., PMID:40377048
Phase 1 study evaluating safety and pharmacokinetics of tusamitamab ravtansine monotherapy in Japanese patients with advanced malignant solid tumors., PMID:40413667
Trace protein detection by graphene-integrated terahertz meta-sensor and enhanced sensitivity using gold nanoparticles-assisted., PMID:40413992
An innovative electrophoresis-coupled electrochemiluminescence immunosensor for rapid and sensitive detection of carcinoembryonic antigen., PMID:40418863
CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma., PMID:40436855
Nanobody-Directed CEA-targeting CAR T Cells Eliminate Gastrointestinal Cancer Xenografts., PMID:40439687
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid Tumors., PMID:40465170
Construction of a simple PEC immunosensing platform based on polydopamine and PEDOT sensitized Bi2WO6 for sensitive detection of carcinoembryonic antigen., PMID:40466205
Application of serum anti-ENO1 and anti-SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer., PMID:40469915
Diagnostic significance of carcinoembryonic antigen and anti-MDA5 antibodies in polymyositis/dermatomyositis-associated rapidly progressive interstitial lung disease., PMID:40516211
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index., PMID:40525496
Estimating residence times and their associated errors in patient absorbed-dose calculation, PMID: 9438927
Breast-tumor xenograft targeting and therapy studies using radiolabeled chimeric anti-cea monoclonal-antibody t84.66, PMID: 21597719
Intrapatient consistency of imaging biodistributions and their application to predicting therapeutic doses in a phase I clinical study of 90Y-based radioimmunotherapy, PMID: 10360545
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer, PMID: 10541368
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients, PMID: 9867150
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer, PMID: 14676105
For research use only. Not for human or drug use.
